Patient Risk Stratification Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Expected Patient Risk Stratification Market Size During the Forecast Period?
In recent times, the patient risk stratification market has witnessed substantial expansion. The market, projected to surge from $2.15 billion in 2024 to $2.82 billion in 2025, is predicted to experience a compound annual growth rate (CAGR) of 31.3%. Factors contributing to this growth during the historic period can be traced back to a surge in digital adoption, an escalation in risk, an aging population, an increasing rate of medical errors, and a growing implementation of electronic health records (EHR).

Expectations are high for a substantial surge in the patient risk stratification market size in the upcoming years, projected to escalate to $8.30 billion by 2029 at a compounded annual growth rate (CAGR) of 31.0%. The predicted expansion for this period is predominantly fueled by the burgeoning middle-class and health insurance sector, an uptick in chronic disease prevalence, widespread embrace of predictive analytics, heightened focus on social determinants of health (SDOH), and the augmented use of technology. The forecast period introduces key inclinations such as breakthroughs in analytics, artificial intelligence (AI), machine learning, significant technological advancement, inventive tools, progress in healTH*Care technologies, wearable technology inclusion, and remote patient monitoring.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20917

What Are the High-Growth Segments in the Patient Risk Stratification Market?
The patient risk stratification market covered in this report is segmented -

1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model
2) By Component: Software, Services
3) By Delivery Model: On-Premise, Cloud-Based
4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications
5) By End User: HealTH*Care Providers, HealTH*Care Payers, Other End Users

Subsegments:
1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models
2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models
3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models
4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20917&type=smp

What Key Drivers Are Expected to Influence Future Patient Risk Stratification Market Growth?
The escalating issue of chronic diseases is anticipated to fuel the expansion of the patient risk stratification market. These enduring health ailments, which usually last for three months or longer, are increasingly common. The surge in chronic disease prevalence can be ascribed to a multitude of factors, including an aging demographic, unhealthy living habits, urban development, environmental influences, inadequate access to healTH*Care, economic inequality, and heightened stress levels. Stratifying patient risk aids in identifying individuals at varying risk degrees for chronic diseases, facilitating customized care, swift intervention, more efficient resource distribution, and enhanced health results. For example, the National Center for Biotechnology Information (NCBI) - a U.S. National Library of Medicine - projected in January 2023 that the count of individuals aged 50 and older suffering from at least one chronic illness will proliferate by 99.5%, surging from 71.522 million in 2020 to 142.66 million by 2050. Moreover, in the World Health Organization's (WHO) 2022 Highlights report from September 2022, it was revealed that 74% of all global deaths were due to chronic diseases, totaling 41 million deaths annually. These include 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, it is clear that the escalating issue of chronic diseases is a key driver of the patient risk stratification market.

Which Companies Hold the Largest Share Across Different Patient Risk Stratification Market Segments?
Major companies operating in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealTH*Care Technologies Inc., Adobe Inc., Persistent Systems, NextGen HealTH*Care Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation

What Trends Are Driving Growth in The Acute Hospital Care Market?
Leading businesses in the patient risk stratification sector are concentrating on healTH*Care technological advancements such as artificial intelligence (AI) in disease screening. This approach enhances earlier detection, improves patient results, and decreases healTH*Care costs by providing more precise risk assessments and customized treatment plans. AI used in disease screening employs advanced algorithms and machine learning to scrutinize medical data, facilitating early detection of diseases and enhancing diagnostic accuracy by rapidly analyzing large volumes of information. For instance, WELL Health Technologies Corporation, a healTH*Care company based in Canada, together with its investee company, HEALWELL AI, another healTH*Care company from Canada specializing in AI and data science for preventive care, launched WELL AI Decision Support (WAIDS) in May 2024. This tool targets rare diseases and now incorporates screening for chronic conditions like kidney disease, hypertension, and diabetes. It can identify over 100 diseases and provide risk stratification, enabling clinicians to spot care gaps and access actionable data at the point of care.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report

What Are the Emerging Geographies for The Patient Risk Stratification Market Growth?
North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Patient Risk Stratification Market?
2. What is the CAGR expected in the Patient Risk Stratification Market?
3. What Are the Key Innovations Transforming the Patient Risk Stratification Industry?
4. Which Region Is Leading the Patient Risk Stratification Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.